David E Calhoun
age ~72
from Orlando, FL
- Also known as:
-
- David H Calhoun
- Favid Calhoun
David Calhoun Phones & Addresses
- Orlando, FL
- Manhasset, NY
- Westlake Village, CA
- 1326 Muirlands Dr, La Jolla, CA 92037 • 8587502098
- Cambridge, NY
- Flushing, NY
- New York, NY
- Washingtonvle, NY
- 1326 Muirlands Dr, La Jolla, CA 92037
Work
-
Position:Professional/Technical
Education
-
Degree:Associate degree or higher
Name / Title
Company / Classification
Phones & Addresses
Owner
Hungry Howie's Pizza
Full-Service Restaurants
Full-Service Restaurants
2400 S French Ave, Sanford, FL 32771
4073214440, 4073245077
4073214440, 4073245077
Owner
California Academy Of Real Est
Real Estate
Real Estate
18817 Napa St, Northridge, CA 91324
8188857828
8188857828
Vice-President
Atpam
Pension/Health/Welfare Fund
Pension/Health/Welfare Fund
62 W 45 St, New York, NY 10036
2127193666
2127193666
Chief Executive Officer
Shelby Tech
Noncommercial Research Organization
Noncommercial Research Organization
41 Linden Ter, Leonia, NJ 07605
2126506934
2126506934
Chief Executive Officer
Nielsen Holdings N.V
Holding Company · Information and Delivery Services
Holding Company · Information and Delivery Services
770 Broadway, New York, NY 10003
SWV LTD
Vice-President
League Atpam Benefit Fund
Trust Management
Trust Management
165 W 46 St, New York, NY 10036
2123980575
2123980575
Owner
Shoes of Birmingham Corporation
Whol Footwear
Whol Footwear
41 Linden Ter, Leonia, NJ 07605
Lawyers & Attorneys
David Calhoun - Lawyer
view sourceOffice:
Wyatt, Tarrant & Combs, LLP
Specialties:
Appellate Practice
Civil Litigation
Insurance
Intellectual Property
Legal Malpractice
Litigation
Torts
Trademarks
Fiduciary Litigation
Litigation & Alternative Dispute Resolution
Intellectual Property Protection & Litigation
Securities Litigation
Insurance Coverage Advice and Litigation
Business and Commercial Litigation
Civil Litigation
Insurance
Intellectual Property
Legal Malpractice
Litigation
Torts
Trademarks
Fiduciary Litigation
Litigation & Alternative Dispute Resolution
Intellectual Property Protection & Litigation
Securities Litigation
Insurance Coverage Advice and Litigation
Business and Commercial Litigation
ISLN:
911255230
Admitted:
1996
University:
University of Louisville, B.A., 1984
Law School:
University of Louisville Law School, J.D., 1996
Medicine Doctors
David Calhoun
view sourceSpecialties:
Cardiovascular Disease
Work:
University Of Alabama Hospital Cardiovascular
619 19 St S, Birmingham, AL 35233
2059349281 (phone), 2059340424 (fax)
UAB Medicine Kirklin Clinic
2000 6 Ave S, Birmingham, AL 35233
2058018817 (phone), 2059341302 (fax)
UAB Highlands Hospital Sleep Medicine
1201 11 Ave S FL 7, Birmingham, AL 35205
2059308202 (phone), 2059308225 (fax)
619 19 St S, Birmingham, AL 35233
2059349281 (phone), 2059340424 (fax)
UAB Medicine Kirklin Clinic
2000 6 Ave S, Birmingham, AL 35233
2058018817 (phone), 2059341302 (fax)
UAB Highlands Hospital Sleep Medicine
1201 11 Ave S FL 7, Birmingham, AL 35205
2059308202 (phone), 2059308225 (fax)
Education:
Medical School
University of Virginia School of Medicine
Graduated: 1986
University of Virginia School of Medicine
Graduated: 1986
Conditions:
Hypertension (HTN)
Insomnia
Obstructive Sleep Apnea
Atrial Fibrillation and Atrial Flutter
Attention Deficit Disorder (ADD)
Insomnia
Obstructive Sleep Apnea
Atrial Fibrillation and Atrial Flutter
Attention Deficit Disorder (ADD)
Languages:
English
Description:
Dr. Calhoun graduated from the University of Virginia School of Medicine in 1986. He works in Birmingham, AL and 2 other locations and specializes in Cardiovascular Disease. Dr. Calhoun is affiliated with University Of Alabama Hospital.
Isbn (Books And Publications)
Recombinant DNA Technology: Concepts and Biomedical Applications
view sourceAuthor
David Calhoun
ISBN #
0132219956
Us Patents
-
Recombinant -Galactosidase A Therapy For Fabry Disease
view source -
US Patent:6461609, Oct 8, 2002
-
Filed:Jan 29, 1997
-
Appl. No.:08/790491
-
Inventors:David Hudgins Calhoun - Leonia NJ
George Coppola - Hartsdale NY -
Assignee:Research Foundation of the City University of New York - New York NY
-
International Classification:A61K 3847
-
US Classification:424 9461, 435208, 4353201
-
Abstract:Fabry disease results from an X-linked deficiency in the enzyme -galactosidase A. The present invention is directed to recombinant human -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of -galactosidase A are also provided.
-
Recombinant Α-Galactosidase A Therapy For Fabry Disease
view source -
US Patent:7011831, Mar 14, 2006
-
Filed:Sep 4, 2002
-
Appl. No.:10/234524
-
Inventors:David Hudgins Calhoun - Leonia NJ, US
George Coppola - Hartsdale NY, US -
Assignee:Research Corporation Technologies, Inc. - Tucson AZ
-
International Classification:A61K 38/47
C12N 9/40
C12N 15/00 -
US Classification:424 9461, 435208, 4353201
-
Abstract:Fabry disease results from an X-linked deficiency in the enzyme α-galactosidase A. The present invention is directed to recombinant human α-galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of α-galactosidase A are also provided.
-
Recombinant .Alpha.-Galactosidase A Therapy For Fabry Disease
view source -
US Patent:51790238, Jan 12, 1993
-
Filed:May 7, 1990
-
Appl. No.:7/520312
-
Inventors:David H. Calhoun - Leonia NJ
George Coppola - Hartsdale NY -
Assignee:Research Corporation Technologies, Inc. - Tucson AZ
-
International Classification:C12N 1500
C12N 940
C12N 1506
C12N 1586 -
US Classification:4353201
-
Abstract:Fabry disease results from an X-linked deficiency in the enzyme. alpha. -galactosidase A. The present invention is directed to recombinant human. alpha. -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of. alpha. -galactosidase A are also provided.
-
Recombinant .Alpha.-Galactosidase A Therapy For Fabry Disease
view source -
US Patent:56585675, Aug 19, 1997
-
Filed:Nov 22, 1993
-
Appl. No.:8/155734
-
Inventors:David Hudgins Calhoun - Leonia NJ
George Coppola - Hartsdale NY -
Assignee:Research Corporation Technologies, Inc. - Tucson AZ
-
International Classification:A61K 3846
A61K 3847
C12N 940
C12N 1554 -
US Classification:424 9461
-
Abstract:Fabry disease results from an X-linked deficiency in the enzyme. alpha. -galactosidase A. The present invention is directed to recombinant human. alpha. -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of. alpha. -galactosidase A are also provided.
-
Novel Alpha-Galactosidase A Derivatives
view source -
US Patent:20170051267, Feb 23, 2017
-
Filed:Aug 22, 2016
-
Appl. No.:15/243637
-
Inventors:- New York NY, US
David Calhoun - Leonia NJ, US -
International Classification:C12N 9/40
-
Abstract:Fabry disease is a rare (incidence approximately 1 in 20,000) X-linked inborn error of glycolipid metabolism caused by a deficiency of the lysosomal enzyme, α-galactosidase A, that leads to early death in affected males due to occlusive disease of the heart, kidney, and brain. The present invention provides a modified alpha-Galactosidase A enzyme derivative with improved stability and catalytic properties. As a result of the present invention, an effective therapeutic effect is achieved with a lower dose of enzyme infused to the patients.
Myspace
Youtube
Plaxo
David Calhoun
view sourcewyalusingPast: SOLDIER at USA Army i am a very compassate person for our troops and my country.i love the outdoors the hunting and fishing is my passion all so.i love the beach .i am very... i am a very compassate person for our troops and my country.i love the outdoors the hunting and fishing is my passion all so.i love the beach .i am very romantic careing loveing guy wishing to live life to its fullest and be happy
Calhoun, David
view sourceWarner Music Group
Classmates
David Calhoun
view sourceSchools:
Central Academy Palatka FL 1970-1974
Community:
Sharon Hudson, Donna Turk, Marcia Downing, Lorraine Bradshaw, Karen Robbins, John Jr
David Calhoun
view sourceSchools:
Oxon Hill Elementary School Oxon Hill MD 1963-1967, Saint Barnabas School Louisville KY 1964-1966, G. Gardner Shugart Junior High School Hillcrest Heights MD 1967-1970
Community:
Tracy Bruder
David Calhoun
view sourceSchools:
Hanover Central High School Cedar Lake IN 1969-1973
Community:
Shelly Eastling
David Calhoun
view sourceSchools:
Riverdale High School Riverdale GA 1979-1981
Community:
Antonio Lester, Denise Davis
David Calhoun
view sourceSchools:
Hazlehurst High School Hazlehurst MS 1984-1988
Community:
Melvin Dumas
David Calhoun
view sourceSchools:
Oldtown High School Oldtown MD 1981-1985
Community:
Roger Piper, Erik Beeman, Michelle Monnett, Mary Allen
David Calhoun
view sourceSchools:
Christ the King School Madisonville KY 1975-1983
Community:
John Baxter
David Calhoun
view sourceSchools:
Saint Elizabeth School Oakland CA 1980-1984
Community:
Kurt Kile, Michael Roberts, Kenneth Ken, Robert Dingman
Googleplus
David Calhoun
Work:
Centresource - Senior Developer (2010)
Birdsong Creative - Designer/Developer (2009-2010)
Birdsong Creative - Designer/Developer (2009-2010)
Education:
University of Alabama - Advertising
About:
Designer, developer at CentreSource, music lover, drummer, Christ follower.
Tagline:
I'm the color green.
David Calhoun
Work:
TN National Guard - PFC (2008)
Jones' Hardwood Floors - Laborer (2008)
Jones' Hardwood Floors - Laborer (2008)
Education:
Northwest Ashe
Relationship:
Married
David Calhoun
Work:
Central stamping - Press operator (2010)
David Calhoun
David Calhoun
David Calhoun
David Calhoun
David Calhoun
News
127 Days: The anatomy of a Boeing quality failure
view source- What happened next in the factory is not entirely clear, yet is just as essential to understanding the quality failures that led to the accident and Boeing CEO David Calhouns own direct admission of a quality escape that led to the accident aboard flight 1282 and triggered the Max 9 grounding.
- Date: Jan 25, 2024
- Category: Business
- Source: Google
US FAA says first 40 inspections of Boeing 737 MAX 9 airplanes complete
view source- B) and FAA safety chief are briefing senators on the investigation on Wednesday. Kirkland Donald will lead a team of outside experts in evaluating quality practices at Boeing Commercial Airplanes and its supply chain and provide recommendations to Boeing CEO David Calhoun and the board of directors.
- Date: Jan 17, 2024
- Category: Business
- Source: Google
Boeing slashes production and delays first 777X delivery to 2022
view source- Were working closely with our customers, suppliers and global partners tomanage the challenges to our industry, bridge to recovery and rebuild to be stronger on the other side, adds chief executive David Calhoun.
- Date: Jul 29, 2020
- Category: More news
- Source: Google
Is It Safe to Buy Airline Stocks Right Now?
view source- Boeing, which counts on the airlines for the bulk of its revenue, is expecting the worst. During a May 12 television interview,CEO David Calhoun said a "major U.S. carrier" will "most likely" go out of business this year, predicting an extended decline in travel.
- Date: May 16, 2020
- Category: Business
- Source: Google
Boeing expected to post another quarterly loss as coronavirus, 737 MAX woes weigh
view source- In a virtual shareholder meeting on Monday, newly appointed CEO David Calhoun painted a dire portrait of the aviation industrys medium-term outlook, warning that it faced years of recovery from the pandemic.
- Date: Apr 28, 2020
- Category: Business
- Source: Google
Boeing-Embraer Deal Collapses
view source- Boeing had envisioned putting Embraer engineers to work on its long-planned new middle-market airplane, but new CEO David Calhoun put the project on the back burner after taking over in January with the company in crisis over the prolonged grounding of its bestselling plane, the 737 MAX, following t
- Date: Apr 25, 2020
- Category: Business
- Source: Google
Struggling Boeing records no new orders in January
view source- But just weeks ago, Boeing announced it would put on hold its plans to develop a new mid-market airplane. David Calhoun, the companys new CEO, said directly that Boeing will not create a new airframe just to compete with the A321neo.
- Date: Feb 12, 2020
- Category: Business
- Source: Google
Boeing collapses NMA and FSA into a single search for its next airplane
view source- Among his first acts as chief executive, David Calhoun sent Boeings 220 to 270-seat New Mid-Market Airplane (NMA) back to the drawing board. Were going to start with a clean sheet of paper again, he said last week.
- Date: Jan 30, 2020
- Category: Business
- Source: Google
David A Calhoun
view source
David Calhoun
view source
David Calhoun Sr
view source
David B Calhoun
view source
David Sybil Calhoun
view source
David Calhoun
view source
David C Calhoun
view source
David L Calhoun
view sourceGet Report for David E Calhoun from Orlando, FL, age ~72